High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma
Also known as: High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma / High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 1 |
| DB14922 | Tislelizumab | 2 | Recruiting | 1 |
| DB06261 | Hexaminolevulinate | 4 | Not Yet Recruiting | 1 |